NDA Partners LLC: A Development Partner to Biopharmaceutical Investors and Companies

John Clark, MD, MPH

Practice Area Focus

  • Drugs
  • Drug Safety
  • Epidemiology


Dr. John Clark joined NDA Partners in 2015. He is a surveillance and signaling expert (including FDA’s FAERS Database) and former FDA Medical Epidemiologist and Chairman of the Monitored Adverse Reactions Committee.

Following his position at FDA, Dr. Clark was Associate Director of Drug Experience and Epidemiology at Merck, Sharp, and Dohme Research Laboratories; Medical Director at Greenwich Pharmaceuticals; Senior Director at Zeneca Pharmaceuticals; Global Head of Corporate Drug Safety and Pharmacoepidemiology at Bracco Diagnostics; and Senior Director of Global Safety for Remicade at Johnson & Johnson. Most recently, he served as Vice President of the Safety Services Unit at Galt Associates, and as Senior Director of Epidemiology and Risk Management at United Biosource Corporation. He worked as a consultant to FDA on the FDA Adverse Event Reporting System (FAERS) and MedWatchPlus projects.

Dr. Clark is currently an Associate Clinical Professor at Temple University’s School of Pharmacy where he teaches the risk management of pharmaceuticals.